Murray, Advocates Applaud FDA’s Decision To Loosen Mifepristone REMS

By Beth Wang / December 16, 2021 at 6:59 PM
A key lawmaker and women’s health advocates applauded FDA’s Thursday (Dec. 16) decision to loosen restrictions on the abortion pill, mifepristone, so that it can be delivered to patients through the mail and dispensed by certain pharmacies. The decision was expected by women’s health advocates, who said loosening up at least some of the prescribing restrictions on mifepristone would allow for the drug to be accessed remotely and possibly even help preserve some access to medication abortion care as an...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.